The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...
Smithsonian Magazine on MSN
The FDA approves the first-ever gene therapy for deafness, which aims to restore hearing in kids with a rare inherited condition
On April 23, the Food and Drug Administration approved the first-ever gene therapy for a rare, congenital form of deafness.
The Daily Galaxy on MSN
FDA approves first-ever gene therapy for deafness and 80 percent of kids could hear within a year
Travis used to sleep through everything. Then his mother laughed in the car and woke him up, the first time he had ever heard ...
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have ...
The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
An experimental gene therapy for a rare form of genetic deafness has successfully restored hearing in children and adults, ...
By Dennis Thompson HealthDay ReporterTHURSDAY, April 23, 2026 (HealthDay News) — A new gene therapy to treat inherited ...
The world’s first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells ...
A new gene therapy tested in China has improved the hearing of 38 people who were born deaf due to mutations in a gene called ...
After gene therapy for a rare form of deafness, 90% of participants in a clinical trial in China had significant improvement ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results